XTANT MEDICAL HOLDINGS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $10.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- XTANT MEDICAL HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $10.80M, a 237.50% increase from fiscal 2024.
- XTANT MEDICAL HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $3.20M, a 36.00% decline from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $5.00M, a 233.33% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.50M, a 376.64% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $10.80M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $3.20M 10-K · filed 2026-03-31 | $3.10M 10-K · filed 2025-03-06 |
| 2023-12-31 | $5.00M 10-K · filed 2025-03-06 | |
| 2022-12-31 | $1.50M 10-K · filed 2024-04-01 | $1.51M 10-K · filed 2023-03-07 |
| 2021-12-31 | $314.71K 10-K · filed 2023-03-07 | $300.00K 10-K · filed 2022-03-08 |
| 2020-12-31 | $11.00M 10-K · filed 2022-03-08 | -$11.00M 10-K · filed 2021-02-24 |
| 2019-12-31 | $1.00M 10-K · filed 2021-02-24 | |
| 2018-12-31 | $7.30M 10-K · filed 2020-03-05 | |
| 2017-12-31 | $6.40M 10-K · filed 2019-04-01 | $6.39M 10-K · filed 2018-04-05 |
| 2016-12-31 | $3.13M 10-K · filed 2018-04-05 | $3.11M 10-K · filed 2017-03-29 |
| 2015-12-31 | $10.97M 10-K · filed 2017-03-29 | $10.42M 10-K · filed 2016-03-24 |
| 2014-12-31 | $4.91M 10-K · filed 2016-03-24 | |
| 2013-12-31 | $4.11M 10-K · filed 2015-03-18 | |
| 2012-12-31 | $2.79M 10-K · filed 2014-03-27 | |
| 2011-12-31 | $2.04M 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |